AU1157500A - Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof - Google Patents

Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof

Info

Publication number
AU1157500A
AU1157500A AU11575/00A AU1157500A AU1157500A AU 1157500 A AU1157500 A AU 1157500A AU 11575/00 A AU11575/00 A AU 11575/00A AU 1157500 A AU1157500 A AU 1157500A AU 1157500 A AU1157500 A AU 1157500A
Authority
AU
Australia
Prior art keywords
lacidipine
telmisartan
combinations
medicaments based
physiological derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11575/00A
Inventor
Giovanni Gaviraghi
Mauro Quartaroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Glaxo Group Ltd
Original Assignee
Boehringer Ingelheim International GmbH
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1998/003336 external-priority patent/WO2000027397A1/en
Application filed by Boehringer Ingelheim International GmbH, Glaxo Group Ltd filed Critical Boehringer Ingelheim International GmbH
Publication of AU1157500A publication Critical patent/AU1157500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11575/00A 1998-11-06 1999-11-03 Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof Abandoned AU1157500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
WO803336 1998-11-06
PCT/GB1998/003336 WO2000027397A1 (en) 1998-11-06 1998-11-06 Antihypertensive medicaments containing lacidipine and telmisartan
US09304884 1999-05-04
US09/304,884 US6071939A (en) 1998-11-06 1999-05-04 Medicaments for the treatment of hypertension
PCT/EP1999/008226 WO2000027396A1 (en) 1998-11-06 1999-11-03 Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof

Publications (1)

Publication Number Publication Date
AU1157500A true AU1157500A (en) 2000-05-29

Family

ID=26313138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11575/00A Abandoned AU1157500A (en) 1998-11-06 1999-11-03 Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof

Country Status (2)

Country Link
AU (1) AU1157500A (en)
WO (1) WO2000027396A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1467712E (en) * 2002-01-16 2008-01-09 Boehringer Ingelheim Pharma Bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide
DE10244681A1 (en) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh New solid telmisartan-containing pharmaceutical formulations and their preparation
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
CN1298389C (en) * 2005-01-18 2007-02-07 广东省人民医院 Compound preparation of calcium antagonist and timishatan for reducing blood pressure and its use
GB0822171D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Temisartan formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746013B1 (en) * 1996-03-18 1998-05-29 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY
ATE239723T1 (en) * 1996-03-29 2003-05-15 Smithkline Beecham Corp EPROSARTANE DIHYDRATE AND A METHOD FOR THE PRODUCTION AND FORMULATION THEREOF
FR2760364A1 (en) * 1997-03-10 1998-09-11 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS FOR REDUCING MORTALITY AFTER MYOCARDIAL INFARCTION

Also Published As

Publication number Publication date
WO2000027396A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU5970298A (en) Dithiolan derivatives, their preparation and their therapeutic effect
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
EP1006110B8 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
GB2327675B (en) Nicotinamide derivatives and their use as medicaments
IL144637A0 (en) Diaryl derivatives and their use as medicaments
AU1042199A (en) Antihypertensive medicaments containing lacidipine and telmisartan
EP1072266B8 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU5416000A (en) Sulfonamide substituted benzylamine derivatives and their use as medicaments
AU6475100A (en) Novel anilide derivatives or salts thereof and drugs containing the same
AU1157500A (en) Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU1782600A (en) Melatonin derivatives and medicine containing same
AU4964597A (en) Benzenesulfonamide derivatives and medicaments comprising said derivatives
AU1887301A (en) Heterocycle derivatives and drugs
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
AU1685201A (en) Drug inducible system and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase